Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A southwest oncology group study

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

1979 • 140 citations

Criteria for Evaluating Patient Responses to Treatment Modalities for Prostatic Cancer

1984 • 86 citations

Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial

1981 • 44 citations

A reexamination of the stable category for evaluating response in patients with advanced prostate cancer

1984 • 34 citations

The Value of Nuclear Bone Imaging in Advanced Prostatic Cancer

1981 • 32 citations

Cyclophosphamide, Methotrexate and 5-Fluorouracil Combination Chemotherapy Versus Chloroethyl-Cyclohexy-Nitrosourea in the Treatment of Metastatic Prostatic Cancer

1982 • 21 citations

Chemotherapy trial with comp-F regimen in advanced adenocarcinoma of prostate

1978 • 15 citations

Prostate cancer: Evaluation of response to treatment, response criteria, and the need for standardization of the reporting of results

1987 • 13 citations